Therapeutic Area

Neuro Inflammation
As a pre-clinical Immunology CRO we test therapeutics that limit and control inflammation within the central nervous system.
There is a growing literature on the contribution of the immune response to neurodegenerative diseases. We have designed assays that test novel therapeutics aimed at preventing or blocking the inflammatory cytokines/chemokines generated by microglial cellsand aspects of microglial function such as phagocytosis.
Example of key assays designed to test therapeutics that modulate immune function of microglial cells
  • Microglia: iPSC derived Microglia phagocytosis, iPSC derived Microglia, cytokine (Inflammasome) /chemokine release
  • Neuron: Neurite out growth
neuroinflammation

Drug Discovery Tool

Find the right immune assay for your therapeutic area, modality and target using our interactive Drug Discovery Tool.

Explore now